{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:42:24Z","timestamp":1771472544374,"version":"3.50.1"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2015,10,29]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              It remains to be determined whether patients receiving cardiac resynchronization therapy (\n              <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n              ) benefit from the addition of an implantable cardioverter\u2010defibrillator (\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              ).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              We performed a literature search looking for studies of patients implanted with\n              <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n              s. Comparisons were performed between patients receiving\n              <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n              \u2010defibrillator (\n              <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n              \u2010D) versus\n              <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n              \u2010pacemaker (\n              <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n              \u2010P). The primary outcome was all\u2010cause mortality. Data were pooled using a random\u2010effects model. The relative risk (\n              <jats:styled-content style=\"fixed-case\">RR<\/jats:styled-content>\n              ) and hazard ratio (\n              <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n              , when available) were used as measurements of treatment effect. Nineteen entries were entitled for inclusion, comprising 12\u00a0378 patients (7030 receiving\n              <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n              \u2010D and 5348 receiving\n              <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n              \u2010P) and 29\u00a0799 patient\u2010years of follow\u2010up. Those receiving\n              <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n              \u2010D were younger, were more often males, had lower\n              <jats:styled-content style=\"fixed-case\">NYHA<\/jats:styled-content>\n              class, lower prevalence of atrial fibrillation, higher prevalence of ischemic heart disease, and were more often on beta\u2010blockers. Ten studies showed significantly lower mortality rates with the\n              <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n              \u2010D device, while the remaining 9 were neutral. The pooled data of studies revealed that\n              <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n              \u2010D patients had significantly lower mortality rates compared with\n              <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n              \u2010P patients (mortality rates:\n              <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n              \u2010D 16.6% versus\n              <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n              \u2010P 27.1%;\n              <jats:styled-content style=\"fixed-case\">RR<\/jats:styled-content>\n              =0.69, 95%\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              0.62\u20130.76;\n              <jats:italic>P<\/jats:italic>\n              &lt;0.00001). The number needed to treat to prevent one death was 10. The observed I\n              <jats:sup>2<\/jats:sup>\n              values showed moderate heterogeneity among studies (I\n              <jats:sup>2<\/jats:sup>\n              =48%). The benefit of\n              <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n              \u2010D was more pronounced in ischemic cardiomyopathy (\n              <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n              =0.70, 95%\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              0.59\u20130.83,\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001, I\n              <jats:sup>2<\/jats:sup>\n              =0%), but a trend for benefit, albeit of lower magnitude, could also be seen in non\u2010ischemic dilated cardiomyopathy (\n              <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n              =0.79, 95%\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              0.61\u20131.02,\n              <jats:italic>P<\/jats:italic>\n              =0.07, I\n              <jats:sup>2<\/jats:sup>\n              =36%).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              The addition of the\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              associates with a reduction in the risk of all\u2010cause mortality in\n              <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n              patients. This seems to be more pronounced in patients with ischemic cardiomyopathy.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.115.002539","type":"journal-article","created":{"date-parts":[[2015,11,7]],"date-time":"2015-11-07T03:18:44Z","timestamp":1446866324000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":26,"title":["Importance of Implantable Cardioverter\u2010Defibrillator Back\u2010Up in Cardiac Resynchronization Therapy Recipients: A Systematic Review and Meta\u2010Analysis"],"prefix":"10.1161","volume":"4","author":[{"given":"S\u00e9rgio","family":"Barra","sequence":"first","affiliation":[{"name":"Cardiology Department, Papworth Hospital NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Provid\u00eancia","sequence":"additional","affiliation":[{"name":"Barts Heart Centre, Barts Health NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Tang","sequence":"additional","affiliation":[{"name":"University of Western Ontario, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Heck","sequence":"additional","affiliation":[{"name":"Cardiology Department, Papworth Hospital NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munmohan","family":"Virdee","sequence":"additional","affiliation":[{"name":"Cardiology Department, Papworth Hospital NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharad","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Cardiology Department, Papworth Hospital NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032423"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050496"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.113.000570"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0906431"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009540"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043399"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033088"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013474"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)04440-2"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.07.087"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8167.2004.04044.x"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.185"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut032"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfr158"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)01229-7"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2014-305537"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)03341-6"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eus247"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/AC.68.1.2959630"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2010.12.091"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/AC.69.5.3044874"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/pace.12631"},{"key":"e_1_3_4_24_2","article-title":"Adding the implantable cardioverter\u2010defibrillator to cardiac resynchronization therapy is associated with improved long\u2010term survival in ischemic, but not in non\u2010ischemic cardiomyopathy","author":"Witt C","year":"2015","unstructured":"Witt C, Kronborg M, Nohr E, Mortensen P, Gerdes C, Jensen H, Nielsen J. Adding the implantable cardioverter\u2010defibrillator to cardiac resynchronization therapy is associated with improved long\u2010term survival in ischemic, but not in non\u2010ischemic cardiomyopathy. Europace. 2015. doi: 10.1093\/europace\/euv212. First published online: September 16, 2015.","journal-title":"Europace"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.10.0719"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(98)00131-0"},{"key":"e_1_3_4_27_2","unstructured":"Ottawa Hospital Research Institute [Internet]; Available at: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed June 1 2015."},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2008.01234.x"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.2217\/fca.09.45"},{"key":"e_1_3_4_31_2","unstructured":"Marijon E. Cause\u2010of\u2010death analysis of patients with cardiac resynchronization therapy\u2014The CeRtiTuDe Cohort Study. Conference. Available at: http:\/\/ondemand.hrsonline.org\/common\/presentation-detail.aspx\/15\/35\/1097\/8585. Accessed June 10 2015."},{"key":"e_1_3_4_32_2","unstructured":"Santos M. Cardiac resynchronization therapy with or without an implantable cardioverter\u2010defibrillator: an insight from real world patients. Conference. Available at: http:\/\/www.spc.pt\/spc\/cpc34\/infores.aspx?id=2449. Accessed June 10 2015."},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(85)90554-X"},{"key":"e_1_3_4_34_2","first-page":"I50","article-title":"Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure","volume":"85","author":"Packer M","year":"1992","unstructured":"Packer M. Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure. Circulation. 1992;85:I50\u2013I56.","journal-title":"Circulation"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108013250501"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198606123142404"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00361-6"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2012.04.021"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.853689"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.112.968867"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl203"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl099"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2013.06.003"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euv008"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2014.11.014"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut339"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2014.01.016"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.01.065"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.011283"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfq171"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.08.038"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht309.P3207"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.152"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0b013e3283638148"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/jce.12496"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.03.025"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.05.011"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.4598"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.11.048"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2014.03.001"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht511"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp421"},{"key":"e_1_3_4_63_2","first-page":"ehv455","article-title":"Causes\u2010of\u2010death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study","author":"Marijon E","year":"2015","unstructured":"Marijon E, Leclercq C, Narayanan K, Boveda S, Klug D, Lacaze\u2010Gadonneix J, Defaye P, Jacob S, Piot O, Deharo JC, Perier MC, Mulak G, Hermida JS, Milliez P, Gras D, Cesari O, Hidden\u2010Lucet F, Anselme F, Chevalier P, Maury P, Sadoul N, Bordachar P, Cazeau S, Chauvin M, Empana JP, Jouven X, Daubert JC, Le Heuzey JY; CeRtiTuDe Investigators . Causes\u2010of\u2010death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study. Eur Heart J. 2015;ehv455 [Epub ahead of print].","journal-title":"Eur Heart J"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2015.05.005"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2010.03.042"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.115.002539","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:26:14Z","timestamp":1715595974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.115.002539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,29]]},"references-count":64,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,10,29]]}},"alternative-id":["10.1161\/JAHA.115.002539"],"URL":"https:\/\/doi.org\/10.1161\/jaha.115.002539","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,29]]},"assertion":[{"value":"2015-08-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-09-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-11-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e002539"}}